Aiforia’s member of the Board of Directors, John Sweeney, resigns from the board

Aiforia Technologies Plc, Company Release, 25 August 2022 at 2p.m. EEST. John Sweeney has today announced that he is leaving the Board of Directors of Aiforia Technologies Plc. John Sweeney, having just resigned from his position as President and CEO of Epredia, therefore felt it to be a natural step to resign from his duties at Aiforia due to Epredia’s collaboration and investment in the company.

"On behalf of the Board of Directors and other stakeholders, I would like to express a big thank you to John for his cooperation and efforts in supporting Aiforia. Epredia’s partnership with Aiforia supports us to commercialize Aiforia’s portfolio of AI-based digital pathology solutions, particularly in the area of cancer diagnostics," explains Jukka Tapaninen, Chief Executive Officer of Aiforia.

Further enquiries

Jukka Tapaninen, CEO, Aiforia Technologies Plc, tel. +33610416686

Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc, tel. +358405009878

https://investors.aiforia.com/

Certified Adviser

UB Securities Ltd, ubs@unitedbankers.fi

About Aiforia

Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more. Find out more: www.aiforia.com